THTX Research and Charts

THTX - Theratechnologies Inc (Healthcare: Drug Manufacturers - Specialty & Generic)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-06-30)

Last 2.36	Change ⇑ +0.01 (+0.43%)	Volume 67,061
	Open 2.34	High 2.39	Low 2.30

8EMA (Daily) 2.41	40EMA (Daily) 2.47	50EMA (Daily) 2.43	STO (Daily) 21.997	MACD Hist (Daily) -0.048
8EMA (Weekly) 2.445	40EMA (Weekly) 1.99	50EMA (Weekly) 1.91	STO (Weekly) 64.737	MACD Hist (Weekly) -0.047


Company Profile
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. The company mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.